Cancer Drug - Cancer Drug,Anti-cancer drug

Cancer Drug

Get up-to-date Cancer Drug news as well as Cancer Drug related headlines such as:last-chance cancer drug,Cancer Drug,Anti-cancer drug etc. Keep touch with the frequently updated news about Cancer Drug to get detail information.

Cancer Drug: News Headlines

• 

  Cancer Drug Manufacturer Bound For Glory: Telik, Inc. (NASDAQ: TELK).

  By Edward Stevenson on April 5, 2010 - ... [+]

  Investment Report on Prospective Pharmaceutical Company: Telik, Inc. (NASDAQ: TELK). Overview of Market Trend in Healthcare Sector, fundamental and brief chart analysis. Read more
  Cancer Drug Manufacturer       healthcare sector       nasdaq       penny stock       TELK

• Study to Examine Last-Chance Cancer Drug

  By RANDOLPH E. SCHMID on March 5, 2005 - The failure of a last-chance cancer drug to significantly improve survival rates in a clinical trial was a surprise and the manufacturer says it is trying to figure... [+]

  out why the product didn't do bette Read more
  cancer       fda       last-chance cancer drug       therapy

• 

  Pain Medications Like Tramadol Hydrochloride Drug Is Now Available Online at...

  By Order Your Prescription Online on July 10, 2010 - Tramadol Hydrochloride Drug is used to relieve moderate to moderately severe pain. It also may be used to treat pain caused by surgery and chronic conditions such... [+]

  as cancer or joint pain. Read more
  tramadol       Tramadol Hydrochloride Drug       tramadol online

Cancer Drug: All News

All news and headlines about Cancer Drug. Browse news on Cancer Drug by date to get detailed information.

• TechNavio Announces the Publication of its Report – Global Cancer Drug Market 2010–2014

  By PR Solutions on February 14, 2012 - TechNavio today published its report Global Cancer Drug Market 2010–2014 based on an in-depth study focusing on the Americas, and the APAC and EMEA regions. ... [+]

  Read more
  

• Anti Cancer medicines, Anti Cancer Drugs, Cheapest Anti Cancer medicines

  By India Internet on February 13, 2012 - 3GChemist is a leading supplier of anti cancer medicines. We are the leading supplier of leading cancer drug in India and is committed to providing you with the... [+]

  highest quality products and services. Read more
  

• Rosa to present at 2012 Keystone Symposia: Cancer and Metabolism

  By Rebecca Baillie on February 2, 2012 - Modeling analysis enables understanding efficacy of large numbers of potential drug combinations. ... [+]

  Read more
  drug development model       oncology       physiological modeling       PhysioPD model       systems pharmacology

• Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from...

  By norton med on January 30, 2012 - The medicine made by Pfizer against advanced kidney cancer was recently approved by Norton Medical and Scientific Research & Biotechnology regulators for commercial... [+]

  use despite a warning of possible s Read more
  business       medical       news       Norton Scientific

• D. Vijay Pharma Private Limited, Mumbai announces the launch of their Business Website

  By dvijaypharma on February 17, 2012 - Established in the year 1975, we at D. Vijay Pharma Pvt. Ltd. are engaged in supplying a wide range of medicines. We are distributor for 8 out of top 10 . ... [+]

  Read more
  cancer       drug       treatment

• Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists

  By Carolyn Rhinebarger on February 1, 2012 - Niiki Pharma announced today the formation of its Scientific Advisory Board. Daniel Haller M.D. will chair the advisory board, and will be joined by Lee Ellis M.D.... [+]

  and Matt Kulke M.D. Read more
  Anti Cancer Drugs       cancer drug development       GRP78       Niiki Pharma Inc.       oncolology product development

• Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics

  By Rebecca Baillie on January 31, 2012 - Industry presenters will focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development ... [+]

  Read more
  cancer       clinical trial analysis       drug development model       model       oncology       physiological modeling and sim       PhysioPD

• Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer...

  By Carolyn Rhinebarger on January 18, 2012 - Niiki Pharma Inc. has completed the dose escalation portion of the Phase I clinical trial of its lead product, NKP-1339, a first-in-class anti-cancer treatment. ... [+]

  Read more
  first in class cancer drug       first in man cancer drug       Niiki Pharma       NKP1339

• Diabetes Drug Actos Possibly Linked to Bladder Cancer

  By BARD-Marketing on January 6, 2012 - The defective drug lawyers at Baker Zimmerman & Perez are investigating Actos claims. ... [+]

  Read more
  Actos       Baker Zimmerman Perez       bladder cancer       diabetes       Drug Recall       fda       prescription drugs       yaz

• C. Glenn Begley, Vice President of Hematology and Oncology to speak at Cancer Targets meeting,...

  By cow721 on December 29, 2011 - C. Glenn Begley, Vice President of Hematology and Oncology to speak at Cancer Targets meeting, Feb 27-28 2012 Las Vegas ... [+]

  Read more
  cancer       Cancer targets       Cancer Therapeutic       cancer vaccine       drug discovery       oncology       Oncology vaccines

• Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

  By rgunnam on December 9, 2011 - The report provides comprehensive information on prostate cancer, highlighting the treatment guidelines. ... [+]

  Read more
  Global Drug       Pharmaceuticals and Healthcare       prostate cancer

• Sutent (Pancreatic Cancer) - Analysis and Forecasts to 2020

  By rgunnam on December 1, 2011 - The report provides detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast... [+]

  period (2010-2020). Read more
  pancreatic cancer       Pharmaceuticals and Healthcare       Sutent

• Takeda to Cut Jobs in Face of Slowing Sales, Loss of Actos Patent Protection

  By Jennifer Poole on January 21, 2012 - Nadrich & Cohen, LLP reports that Japanese drug-maker Takeda Pharmaceuticals is expected to significantly reduce its global workforce. ... [+]

  Read more
  Actos       actos attorney       Actos Bladder Cancer       actos class action       Actos Lawsuit       actos lawyer       actos litigation       takeda pharmaceuticals

• John Herrmann at Eli Lilly to present at Oncology Partnering Conference – Feb 27-28, 2012, Las...

  By GTC on December 31, 2011 - John Herrmann, Senior Director, Global External R&D, Oncology at Eli Lilly to give a Featured Presentation at the Oncology Partnering and Deal-making Conference... [+]

  (February 27-28, 2012 in Las Vegas, NV) Read more
  Cancer Drug Combinations       cancer drugs       cancer therapy       companion diagnostics       oncology

• Denis Patrick at Pfizer to present at Oncology Partnering Conference - Oct 27-28, 2012, Las Vegas

  By GTC on December 31, 2011 - Denis Patrick, Senior Director & Head, External R&D Innovation, Oncology Research Unit at Pfizer to give a Featured Presentation at the Oncology Partnering... [+]

  and Deal-making Conference Read more
  Cancer Drug Combinations       Cancer targets       cancer therapy       companion diagnostics

• Anne Altmeyer, Novartis to speak at Oncology Partnering Conference – Feb 27-28, 2012, Las Vegas

  By GTC on December 30, 2011 - Anne Altmeyer, Executive Director, Business Development & Licensing, Oncology, at Novartis as a Panelist at the Oncology Partnering and Deal-making Conference... [+]

  (February 27-28, 2012 in Las Vegas, NV) Read more
  BiTE antibodies       cancer       Cancer Drug Combinations       companion diagnostics       dealmarking       oncology       partnering       T lymphocytes

• Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020

  By rgunnam on November 29, 2011 - The report provides detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast... [+]

  period (2016-2020). Read more
  clinical assessment       Hyper Acute Pancreas       Pharmaceuticals and Healthcare

• SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis

  By Alexander Sigalov on January 10, 2012 - SignaBlok, Inc., a Massachusetts-based startup, was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach... [+]

  to sepsis (blood poisoning). Read more
  Biotech       cancer treatments       drug delivery       drug discovery       nanotechnology       new therapies       peptide therapeutics       Sepsis Therapeutics

Cancer Drug

Here delivers top news on Cancer Drug. You can get the freshest information from total 398 news.